The Prognostic Impact of Anti-thrombotic Treatment Strategies After Biological Aortic Valve Replacement.
Andreas HammerFelix HoferNiema KazemLorenz KollerSebastian SchnaubeltGünther LauferBarbara SteinlechnerJohann WojtaChristian HengstenbergAlexander NiessnerPatrick SulzgruberPublished in: Cardiovascular drugs and therapy (2021)
Within this investigation, therapeutic AC showed a strong and independent inverse association with long-term mortality in patients that underwent biological AVR. Although POAF is associated with thromboembolic adverse events, the development of this arrhythmia did not affect decision-making of the anti-thrombotic management.